using mrd to inform cll treatment in a clinical trial
Published 6 years ago • 100 plays • Length 3:27Download video MP4
Download video MP3
Similar videos
-
1:27
using mrd to guide treatment decisions in the clinic
-
3:26
miracle study: using an mrd-guided strategy to direct treatment duration in previously untreated cll
-
2:25
the clinical use of mrd in cll and challenges in this space
-
1:38
using mrd as an endpoint in clinical trials
-
1:29
future research into mrd-guided treatment of cll
-
9:03
iccs education: minimal/measurable residual disease testing (mrd) by flow cytometry in bll
-
49:36
experience with mm mrd in our clinical laboratory: theory and practice
-
8:57
outcomes of sct in t-all and t-lbl
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
1:36
the utility of mrd for predicting treatment outcomes in patients with cll
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
1:33
the difficulties of mrd detection in dlbcl
-
1:11
integrating mrd data into treatment decisions in cll
-
1:39
using mrd to inform allocation of stem cell transplants in all and aml
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
2:55
using mrd to guide treatment decisions during sct in multiple myeloma
-
1:49
bringing precision medicine and mrd into clinical strategies
-
1:00
using molecular features to determine appropriate treatment strategies for patients with cll
-
1:46
standardization mrd monitoring in clinical trials
-
3:05
mrd assessment in cll
-
1:03
personalizing aml treatment by targeting mrd mutations
-
1:35
usefulness of mrd in treatment of cll